Firan Technology Group is undervalued, says Paradigm Capital

Following the company’s annual general meeting, Paradigm Capital analyst Daniel Kim is feeling bullish about Firan Technology Group (Firan Technology Stock Quote, Chart, News: TSX:FTG).

In a research update to clients today, Kim maintained his “Buy” rating and one-year price target of $5.75 on Firan Technology Group, implying a return of 38 per cent at the time of publication, including dividend.

Kim says despite the fact that he has had numerous upward revisions to his forecasts, he continues to see a company in Firan whose margins are “on the tipping point” of a major inflection that should drive another material uptick in revenue and margins.

“Recent acquisitions (with more to come) and new programs promise to deliver terrific growth, both top line and importantly, bottom line leverage, with 30% EBITDA contribution from acquired assets,” the analyst says. “Emerging still are new programs, new products, growing cross selling opportunities and a potentially massive increase in utilization in the company’s China JV.”

Kim thinks Firan will generate Adjusted EBITDA of $13.5-million on revenue of $105.7-million in fiscal 2017. He expects those numbers will improve to EBITDA of $19.4-million on a topline of $117.8-million the following year.

Tagged with: ftg
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

8 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

8 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

8 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

8 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

9 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

9 hours ago